Blood clots, known as deep-vein thrombosis, affect the large blood vessels of the lower leg and thigh. They are responsible for killing hundreds of people worldwide, esp. After joint replacement surgery. If the clot breaks down and moves through the bloodstream, it can stay in the lungs, known as pulmonary embolism, which is often fatal.
Treating blood clots with syringes after joint surgery can be painful and can lead to bleeding. Now, the New England Journal of Medicine reports that the international team has found a better way to prevent fatal blood clots without increasing the risk of bleeding.
In a double-blind study of over 3,000 patients, the researchers tested a new type of coagulation drug called apixaban, an oral ation. The drug has proven effective in preventing clots and reduces the risk of bleeding by half. It is very easy to use, mainly for the convenience of patients, he said. This is an important step in our fight to prevent DVT, and many unnecessary deaths occur every year from blood clots following joint replacement surgery.
“We now have better treatment that reduces the risk of bleeding, and the patient no longer has to tolerate injections with a needle,” said University of Oklahoma team captain Gary Rascob.